4//SEC Filing
Hunt Hazel 4
Accession 0000950170-24-091049
CIK 0001088856other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 6:31 PM ET
Size
8.4 KB
Accession
0000950170-24-091049
Insider Transaction Report
Form 4
Hunt Hazel
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2024-08-01$37.94/sh−34,773$1,319,288→ 118,581 total - Exercise/Conversion
Common Stock
2024-08-01$2.81/sh+60,000$168,600→ 153,354 total - Exercise/Conversion
Stock Option (right to buy)
2024-08-01−60,000→ 0 totalExercise: $2.81Exp: 2024-09-11→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on September 11, 2024.
- [F2]Fully exercisable.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001698307
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 6:31 PM ET
- Size
- 8.4 KB